Inspira Technologies announced a $27 million purchase order from a national ministry of health in Africa for their FDA-cleared ART100 systems. This order will accelerate revenue for the company and continue momentum with more orders expected to follow. The Ministry of Health selected the ART100 due to its proven performance in Tier-1 hospitals in the U.S. Deliveries are set to continue throughout 2025 under a nationwide roll-out schedule. Inspira Technologies specializes in advanced respiratory support and real-time blood monitoring solutions, positioning them as an attractive player in the life-support and MedTech landscape.

Read more at GlobeNewswire: Inspira Secures $27 Million Government Binding Purchase